Reviva Pharmaceuticals Holdings Inc (NAS:RVPH)
$ 1.365 -0.005 (-0.36%) Market Cap: 38.11 Mil Enterprise Value: 26.47 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Reviva Pharmaceuticals Holdings, Inc. at OTC Markets Life Sciences Virtual Investor Forum Transcript

Jun 23, 2022 / 05:00PM GMT
Release Date Price: $1.15
Richard Hantke
Zacks Small-Cap Research - Moderator

Hello, and welcome to Virtual Investor Conferences. My name is Richard Hantke, and on behalf of OTC Markets and Zacks Small-Cap Research, we're very pleased you have joined us for the Life Sciences Investor Forum. The next session will be a fireside chat with Reviva Pharmaceuticals and Zacks Small-Cap Research.

(Operator Instructions) On a final note, all of today's presentations will be recorded and available for 24/7 replay. At this point, I'm very pleased to welcome Lax Bhat, Founder, Chief Executive Officer, and President of Reviva Pharmaceutical Holdings, and John Vandermosten, Senior Biotech Analyst with Zacks Small Cap Research. Reviva Pharmaceuticals trades on Nasdaq under the symbol RVPH. Welcome, Lax and John.

Lax Bhat
Reviva Pharmaceuticals Holdings, Inc. - Founder, President, & CEO

Thanks, Richard.

John Vandermosten
Zacks Small-Cap Research - Moderator

All right. Thank you, Richard. And as he said, I am John Vandermosten, the analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot